$10,000 of MYRIAD GENETICS INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to veterans' depression and the Genesight product."
You can find more data on corporate lobbying on Quiver Quantitative.
MYGN Insider Trading Activity
MYGN insiders have traded $MYGN stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MYGN stock by insiders over the last 6 months:
- S. LOUISE PHANSTIEL has made 3 purchases buying 104,507 shares for an estimated $494,722 and 0 sales.
- SAMRAAT S. RAHA (President and CEO) purchased 40,000 shares for an estimated $199,844
- RASHMI KUMAR sold 15,000 shares for an estimated $66,843
- PAUL BISARO purchased 7,500 shares for an estimated $27,637
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MYGN Hedge Fund Activity
We have seen 90 institutional investors add shares of MYGN stock to their portfolio, and 103 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 6,414,206 shares (-41.9%) from their portfolio in Q1 2026, for an estimated $28,863,927
- STATE STREET CORP removed 1,542,540 shares (-25.9%) from their portfolio in Q1 2026, for an estimated $6,941,430
- ACADIAN ASSET MANAGEMENT LLC added 1,322,441 shares (+134.1%) to their portfolio in Q1 2026, for an estimated $5,950,984
- HRT FINANCIAL LP added 1,317,451 shares (+281.0%) to their portfolio in Q1 2026, for an estimated $5,928,529
- JANE STREET GROUP, LLC added 1,148,114 shares (+2109.8%) to their portfolio in Q1 2026, for an estimated $5,166,513
- MARSHALL WACE, LLP added 1,081,456 shares (+4849.1%) to their portfolio in Q1 2026, for an estimated $4,866,552
- GLENVIEW CAPITAL MANAGEMENT, LLC added 824,571 shares (+18.0%) to their portfolio in Q1 2026, for an estimated $3,710,569
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MYGN Price Targets
Multiple analysts have issued price targets for $MYGN recently. We have seen 3 analysts offer price targets for $MYGN in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $5.5 on 05/06/2026
- Kyle Boucher from TD Cowen set a target price of $6.0 on 05/06/2026
- Lu Li from UBS set a target price of $6.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
